CAS 111753-73-2

Satigrel

Description:

Satigrel, with the CAS number 111753-73-2, is a chemical compound that functions primarily as an antiplatelet agent. It is designed to inhibit platelet aggregation, thereby reducing the risk of thrombus formation, which is crucial in the management of cardiovascular diseases. Satigrel acts by targeting specific receptors involved in platelet activation, leading to a decrease in the overall platelet response to stimuli. This compound is characterized by its relatively selective action, which minimizes the risk of excessive bleeding compared to other antiplatelet therapies. Additionally, Satigrel has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, which are essential for determining its efficacy and safety profile in clinical settings. Its development is part of ongoing research into improving therapeutic options for patients at risk of thrombotic events, particularly those with conditions such as coronary artery disease. As with any pharmaceutical agent, the specific characteristics, including dosage and potential side effects, are determined through rigorous clinical trials and regulatory assessments.

Formula: C₂₀H₁₉NO₄

InChI: InChI=1S/C20H19NO4/c1-24-17-8-3-14(4-9-17)20(16(13-21)7-12-19(22)23)15-5-10-18(25-2)11-6-15/h3-6,8-11H,7,12H2,1-2H3,(H,22,23)

InChI key: InChIKey=GRVCTHTXJDYIHB-UHFFFAOYSA-N

SMILES: C(=C(CCC(O)=O)C#N)(C1=CC=C(OC)C=C1)C2=CC=C(OC)C=C2

Synonyms:

• 4-Pentenoic acid, 4-cyano-5,5-bis(4-methoxyphenyl)-
• E 5510
• Satigrel
• 4-Cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid

Satigrel

CAS: 111753-73-2

Satigrel is a new antiplatelet agent. It also inhibits platelet accumulation in prosthetic arterial grafts.

Formula: C₂₀H₁₉NO₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 337.37

Ref: TM-T24760